Literature DB >> 18028492

Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients.

N Hatta1, M Yamada, T Hirano, A Fujimoto, R Morita.   

Abstract

BACKGROUND: Extramammary Paget's disease (EMPD) is a rare cutaneous carcinoma usually presenting as a genital erythematous lesion in the elderly. Although most EMPD tumours are in situ, invasive EMPD has a poor prognosis.
OBJECTIVE: To evaluate the clinical and pathological features of EMPD and determine prognostic factors for survival.
METHODS: The medical records of 76 patients with EMPD were retrospectively reviewed.
RESULTS: Of the 66 patients who underwent curative surgical excision, five (8%) developed local recurrence, but surgical margin (<or=2 cm or >2 cm) was not correlated with local recurrence. Thirteen of the 76 patients (17%) developed systemic metastases and 10 of these died of disease. On univariate analysis, the presence of nodules in the primary tumour, clinical lymph node swelling, elevated serum carcinoembryonic antigen (CEA) levels, tumour invasion level and lymph node metastasis were significant prognostic factors. On multivariate analysis, invasion level and elevated serum CEA were the only factors that were significantly associated with reduced survival.
CONCLUSIONS: Invasion level and lymph node metastasis are important prognostic factors in EMPD. In patients with in situ tumour, local tumour control is the major aim of treatment; however, wide surgical margins are not associated with a lower risk of local recurrence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028492     DOI: 10.1111/j.1365-2133.2007.08314.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  48 in total

1.  The Effectiveness of Mapping Biopsy in Patients with Extramammary Paget's Disease.

Authors:  Byung Jun Kim; Shin Ki Park; Hak Chang
Journal:  Arch Plast Surg       Date:  2014-11-03

2.  Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.

Authors:  Zhihua Kang; Qiaoan Zhang; Qunfeng Zhang; Xiangyu Li; Tingting Hu; Xiao Xu; Zhiyuan Wu; Xinju Zhang; Hua Wang; Jinhua Xu; Feng Xu; Ming Guan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease.

Authors:  Yasutaka Tokuda; Fuyuko Arakura; Hisashi Uhara
Journal:  Int J Clin Oncol       Date:  2014-04-02       Impact factor: 3.402

Review 4.  [Differential diagnosis of anal eczema].

Authors:  A Dietrich; T Ruzicka; C Hermans
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

5.  Extramammary Paget's disease of the perianal region treated successfully with radiotherapy.

Authors:  Bulent Yasar; Sirin Yasar; Pembegul Gunes
Journal:  Int J Colorectal Dis       Date:  2014-10-17       Impact factor: 2.571

6.  High Risk of Proximal and Local Neoplasms in 2206 Patients With Anogenital Extramammary Paget's Disease.

Authors:  Grace C Lee; Hiroko Kunitake; Caitlin Stafford; Liliana G Bordeianou; Todd D Francone; Rocco Ricciardi
Journal:  Dis Colon Rectum       Date:  2019-11       Impact factor: 4.585

7.  Clinical characteristics and risk factors of invasion in extramammary Paget's disease of the vulva.

Authors:  Shanhui Liang; Juan Wang; Huaying Wang; Yulan Ren
Journal:  Arch Gynecol Obstet       Date:  2020-09-29       Impact factor: 2.344

8.  Extramammary Paget's disease with the appearance of a nodule: a case report.

Authors:  Xia Wang; Wenlin Yang; Jian Yang
Journal:  BMC Cancer       Date:  2010-08-04       Impact factor: 4.430

9.  [Extramammary Paget disease: successful therapy with imiquimod 5% cream].

Authors:  G Wagner; M Heine; M M Sachse
Journal:  Hautarzt       Date:  2012-01       Impact factor: 0.751

Review 10.  Surgical Treatment for Extramammary Paget's Disease.

Authors:  Uwe Wollina; Alberto Goldman; Andrzej Bieneck; Mohamed Badawy Abdel-Naser; Sven Petersen
Journal:  Curr Treat Options Oncol       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.